Acute Ischemic Stroke Registry for Endovascular Treatment

Status Recruiting

Clinical Trial Summary

The Acute Ischemic Stroke Registry for Endovascular Treatment (AIS-EVT) is an academic, prospective, multicenter, observational registry study. Consecutive stroke patients treated with endovascular treatment will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05213754
Study type	Observational [Patient Registry]
Source	Capital Medical University
Contact	Xunming Ji, MD
Phone	010-83198952
Email	[email protected]
Status	Recruiting
Phase
Start date	January 1, 2021
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04069546` - The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency	N/A
Recruiting	`NCT04415164` - Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke	Phase 4
Recruiting	`NCT05070260` - Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke	Phase 2/Phase 3
Completed	`NCT03366818` - New Stent Retriever, VERSI System for AIS	N/A
Not yet recruiting	`NCT04984577` - Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke	Phase 2
Completed	`NCT02223273` - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke)	N/A
Completed	`NCT02586233` - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke	Phase 1/Phase 2
Not yet recruiting	`NCT01594190` - Physical Activity Immediately After Acute Cerebral Ischemia	N/A
Terminated	`NCT01694381` - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor	Early Phase 1
Completed	`NCT01120301` - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)	Phase 3
Completed	`NCT01021319` - Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI)
Completed	`NCT00963989` - Imaging Guided Patient Selection for Interventional Revascularization Therapy	N/A
Recruiting	`NCT00710164` - Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke	Phase 2/Phase 3
Completed	`NCT00777140` - Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion	Phase 2
Recruiting	`NCT04072705` - Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
Not yet recruiting	`NCT03669653` - Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke	N/A
Not yet recruiting	`NCT04488692` - Early Functional Training in Acute Stroke Inpatient Ward	N/A
Completed	`NCT04240470` - Endovascular Stroke Treatment Only (ESTO) Trial	N/A
Active, not recruiting	`NCT05101668` - Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke	N/A
Recruiting	`NCT03680469` - The Effectiveness of Early Mobilization for Acute Ischemic Stroke Treated With Rt-PA or IA Thrombectomy	N/A